My thinking is the two big movers soon (announcements) will be
1) Lumos using their USA manufacturing (building now) for the FebriDX (an agreement with Atomo to manufacture) *this is my hunch of connecting the dots re Lumos and their preIPO and building plants and FebriDX being a core product of theirs*
2) the US FDA approval for the AB tests.
The India approvals I wonder if it will be a big mover. I hope so, but it would be third cab off my rank. But I sure await that cab - and to see if a billion people try to get into it.
If one can anticipate announcements you will know how to position your holdings - and not be surprised. I dont even worry if this quarterly does not show huge numbers. I think, as FinFree notes, the announcements and revenue follow a pattern.... and revenue comes in last!
- we have agreement with partners to do something
- we await approval from govts to allow that something
- when approvals come, we then plan with partners how/when to implement the something
- we implement the something = THE REVENUE START
- we continue/grow implementing the something = THE REVENUE FLOW
The different products / plans are at different stages. I really think we have this fin year locked in at about $15 mill revenue. Well, between $11 mill and $15 mill - just continuing the last quarter good momentum. It will be interesting to see how LUMPY the $15 mill will come. And recall the last quarterly had missing revenue that will come THIS quarter. The quarterlies are cash flow based. In the end, I care more re ebitda and earnings per share - which you see in half yearlies.
But, I will guess, and I am hoping for a cash revenue/receipts number of $2.5+ mill for Q1. That will look mighty nice. To get to my $15 mill revenue for the fy, I guess $2.75, then $3.5, then $4.25, then $5.25 mill per qtr does it.
And recall if we simply double revenue each year, then in 4 or 5 years we are on much increased share price. So for FY21 to double the $5.4 mill of revenue this past year, we only need $11 mill. So we can steady as she goes do something like 2 mill, 2.5 mill, 3 mill, 3.5 mill over the year.
Surely, Mr Market will be excited by any revenue/receipts at or over $2 mill. And at $2.5 mill Mr Market will go to into postive meltdown and we can dust off the $1 per share thread.
- Forums
- ASX - By Stock
- AT1
- AT1 FY21 - General Discussion + FA
AT1 FY21 - General Discussion + FA, page-26
-
- There are more pages in this discussion • 2,408 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.001(4.35%) |
Mkt cap ! $15.34M |
Open | High | Low | Value | Volume |
2.3¢ | 2.5¢ | 2.3¢ | $4.884K | 212.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 484493 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 99438 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 484493 | 0.023 |
8 | 992295 | 0.022 |
5 | 262292 | 0.021 |
3 | 299998 | 0.020 |
2 | 78999 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 99438 | 1 |
0.025 | 269579 | 3 |
0.026 | 390045 | 2 |
0.027 | 255550 | 2 |
0.028 | 155890 | 3 |
Last trade - 13.32pm 31/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online